<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11863128</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.540</article-id><article-id pub-id-type="other">EPP0378</article-id><article-id pub-id-type="pii">S0924933824005406</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Comparison of Staging Methods for Treatment-Resistant Depression: Chart Review</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Avano&#x0011f;lu</surname><given-names>K. B.</given-names></name><xref rid="aff1220" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0401" ref-type="corresp">
<sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Oktar Erdo&#x0011f;an</surname><given-names>N.</given-names></name><xref rid="aff1221" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>A&#x0011f;ao&#x0011f;lu</surname><given-names>E.</given-names></name><xref rid="aff1222" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ba&#x0015f;ar</surname><given-names>K.</given-names></name><xref rid="aff1223" ref-type="aff">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="aff1220">
<sup>1</sup>Psychiatry, <institution>Yalova State Hospital</institution>, <city>Yalova</city>
</aff><aff id="aff1221">
<sup>2</sup>Psychiatry, <institution>Pamukkale University Faculty of Medicine</institution>, <city>Denizli</city>
</aff><aff id="aff1222">
<sup>3</sup>Psychiatry, <institution>Bah&#x000e7;elievler Medipol Hospital</institution>, <city>&#x00130;stanbul</city>
</aff><aff id="aff1223">
<sup>4</sup>Psychiatry, <institution>Hacettepe University</institution>, Faculty of Medicine, <city>Ankara</city>, <country>T&#x000fc;rkiye</country>
</aff><author-notes><corresp id="cor0401">
<label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="515">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S255</fpage><lpage>S256</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824005406a.pdf"/><abstract><sec id="sec2407"><title>Introduction</title><p>Treatment-resistant depression (TRD) lacks a universally consistent definition due to varied interpretations despite attempts to define it based on inadequate response or remission despite sufficient antidepressant treatment. There&#x02019;s a crucial demand for a uniform definition and staging to streamline its effective management amid diverse treatment options and the complex nature of resistance. Five methods have emerged to define and classify treatment resistance reliably.</p></sec><sec id="sec2408"><title>Objectives</title><p>
The aim of this study is to compare the five staging methods (Thase&#x00026;Rush SM (T&#x00026;R), European Staging Method (ESM), Maudsley Staging Method (MSM), Massachusetts General Hospital Staging Method (MHG-s), Conway Staging Method(Conway)) in assessing treatment resistance within a single sample.</p></sec><sec id="sec2409"><title>Methods</title><p>
Retrospective analysis involved medical records of inpatient psychiatry clinic admissions at Hacettepe University between October 2012 and October 2014. Patients with a primary diagnosis of bipolar affective disorder, schizophrenia, other chronic psychotic disorders, dementia or cognitive disorders, alcohol and substance use disorders, and those with missing data were excluded.</p></sec><sec id="sec2410"><title>Results</title><p>Initial screening yielded a total of 115 patients. 64 patients were included in the study, 13 patients were excluded due to missing data, and 38 patients were excluded due to comorbidity.<table-wrap position="anchor" id="tab13"><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Characteristic</th><th align="center" valign="middle" rowspan="1" colspan="1">Total (N=64)</th><th align="center" valign="middle" rowspan="1" colspan="1">
Last Episode Characteristics</th><th align="center" valign="middle" rowspan="1" colspan="1">Total (N=64)</th></tr></thead><tbody><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Female - N(%)</td><td align="center" valign="middle" rowspan="1" colspan="1">44 (69)</td><td align="center" valign="middle" rowspan="1" colspan="1">Episode duration &#x02013; month (mean &#x000b1; SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">13.75 &#x000b1; 16.09</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Age &#x02013; yr (mean &#x000b1; SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">48.39 &#x000b1; 18.81</td><td align="center" valign="middle" rowspan="1" colspan="1">Psychotic symptoms &#x02013; N(%)</td><td align="center" valign="middle" rowspan="1" colspan="1">20 (31)</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Married &#x02013; N(%)</td><td align="center" valign="middle" rowspan="1" colspan="1">41 (64)</td><td align="center" valign="middle" rowspan="1" colspan="1">Anxiety symptoms &#x02013; N(%)</td><td align="center" valign="middle" rowspan="1" colspan="1">24 (38)</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Secondary school and over &#x02013; N(%)</td><td align="center" valign="middle" rowspan="1" colspan="1">38 (59)</td><td align="center" valign="middle" rowspan="1" colspan="1">Suicidal attempt &#x02013; N(%)</td><td align="center" valign="middle" rowspan="1" colspan="1">19 (30)</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Employed &#x02013; N(%)</td><td align="center" valign="middle" rowspan="1" colspan="1">16 (25)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><graphic xlink:href="S0924933824005406-TABU0013" position="anchor"/></alternatives></table-wrap>
<table-wrap position="anchor" id="tab14"><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th align="justify" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">TRD definition and staging method (N=55)</italic>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
T&#x00026;R</th><th align="center" valign="middle" rowspan="1" colspan="1">
ESM</th><th align="center" valign="middle" rowspan="1" colspan="1">
MSM</th><th align="center" valign="middle" rowspan="1" colspan="1">
MGH-S
</th><th align="center" valign="middle" rowspan="1" colspan="1">
Conway</th></tr></thead><tbody><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Not resistant by this method</td><td align="center" valign="middle" rowspan="1" colspan="1">26 (47.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">45 (81.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">27 (49.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">43 (78.2)</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Identified by this method</td><td align="center" valign="middle" rowspan="1" colspan="1">29 (52.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">10 (18.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">55 (100)</td><td align="center" valign="middle" rowspan="1" colspan="1">28 (50.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">12 (21.8)</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">Exclusively identified by this method</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">21 (38.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">By this and one other method</td><td align="center" valign="middle" rowspan="1" colspan="1">27 (49.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">11 (20)</td><td align="center" valign="middle" rowspan="1" colspan="1">5 (9.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td></tr><tr><td align="justify" valign="middle" rowspan="1" colspan="1">By all methods</td><td align="center" valign="middle" rowspan="1" colspan="1">10 (18.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">10 (18.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">10 (18.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">10 (18.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">10 (18.2)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">Identified as TRD</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age of onset 
(mean &#x000b1; SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">40.28 &#x000b1; 17.42</td><td align="center" valign="middle" rowspan="1" colspan="1">35.6 &#x000b1; 18.27</td><td align="center" valign="middle" rowspan="1" colspan="1">40.44 &#x000b1;18.38</td><td align="center" valign="middle" rowspan="1" colspan="1">40.07 &#x000b1; 17.9</td><td align="center" valign="middle" rowspan="1" colspan="1">38.17 &#x000b1; 17.71</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ATHF score 
(mean &#x000b1; SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.55 &#x000b1; 5.46</td><td align="center" valign="middle" rowspan="1" colspan="1">12.1 &#x000b1; 6.51</td><td align="center" valign="middle" rowspan="1" colspan="1">4.93 &#x000b1; 4.98</td><td align="center" valign="middle" rowspan="1" colspan="1">7.43 &#x000b1; 5.69</td><td align="center" valign="middle" rowspan="1" colspan="1">11.08 &#x000b1; 6.47</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Last episode duration (month) 
(mean &#x000b1; SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">17.11 &#x000b1; 17.25</td><td align="center" valign="middle" rowspan="1" colspan="1">22.10 &#x000b1; 20.96</td><td align="center" valign="middle" rowspan="1" colspan="1">14.22 &#x000b1; 17.08</td><td align="center" valign="middle" rowspan="1" colspan="1">16.33 &#x000b1; 17.66</td><td align="center" valign="middle" rowspan="1" colspan="1">20.83 &#x000b1; 19.25</td></tr></tbody></table><graphic xlink:href="S0924933824005406-TABU0014" position="anchor"/></alternatives></table-wrap>
</p></sec><sec id="sec2411"><title>Conclusions</title><p>
There is no universally agreed-upon definition for treatment resistance. In this sample, different definition and staging methods were employed to examine the similarities and differences in the clinical and treatment related characteristics of groups with TRD identified with each. The reasons and possible implication of concurrence and discordance between the methods will be discussed.</p></sec><sec id="sec2412"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>